Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.
| Revenue (TTM) | $145.68B |
| Gross Profit (TTM) | $19.89B |
| EBITDA | $3.60B |
| Operating Margin | 3.46% |
| Return on Equity | 6.89% |
| Return on Assets | 3.90% |
| Revenue/Share (TTM) | $1211.44 |
| Book Value | $160.00 |
| Price-to-Book | 2.54 |
| Price-to-Sales (TTM) | 0.33 |
| EV/Revenue | 0.386 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 27.10% |
| Quarterly Revenue Growth (YoY) | 26.20% |
| Shares Outstanding | $120.08M |
| Float | $119.81M |
| % Insiders | 0.21% |
| % Institutions | 101.00% |
Volatility is currently contracting
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026. About Humana Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best heal.
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program. Scholarships provide up to $3,000 for postsecondary education, including degree, vocational and technical programs, for children of Humana employees. Annual awards are renewable for up to three years or until completion of a degree or program with a total possible award of $12,000.
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
Following a parade of health insurance company earnings reports this summer, stocks are rising and costs appear to be under control for now.
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.
Joel Greenblatt's Gotham Asset Management disclosed a defensive tilt in its Q2 2026 13F, filed in mid-August, headlined by a $2.65 billion add to the SPDR S&P 500 ETF and outsized conviction buys in managed care, packaged foods, and Manhattan office real estate.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HUM and any ticker you trade — then tracks every position and per-strategy win rate.
